# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cantor Fitzgerald analyst Brandon Folkes reiterates Aziyo Biologics (NASDAQ:AZYO) with a Overweight and maintains $8 price t...
– Company to begin trading under new ticker symbol "ELUT" – SILVER SPRING, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- A...
Case provides first histologic evidence that CanGaroo can catalyze development of new healthy tissue layer within an existing c...
Cantor Fitzgerald analyst Brandon Folkes reiterates Aziyo Biologics (NASDAQ:AZYO) with a Overweight and maintains $8 price t...
Aziyo Biologics (NASDAQ:AZYO) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0...
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per ...